Hopman Mark sold BBNX
March 2, 2026 · Form 4 insider transaction
Hopman Mark sold 834 shares of Beta Bionics, Inc. at $12.36 per share, a transaction worth $10.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
834
Price
$12.36
Total value
$10.3K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 2, 2026
Filing dateMarch 3, 2026
Shares owned after139,486
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.; The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.